SCHEMBL23267598

SCHEMBL23267598

CCCOCC(=O)N1CCC(C)CC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.53
▸ NPC1 O15118 2/20 0.53
▸ TSHR P16473 2/20 0.47
▸ HPGD P15428 6/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ ATM Q13315 2/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ LMNA P02545 3/20 0.43
▸ GLA P06280 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18330456 0.86 ALDH1A1 (0.56) ALDH1A1NPC1TSHRHPGDKDM4E
SCHEMBL25581265 0.83 ALDH1A1 (0.42) ALDH1A1NPC1TSHRHPGDL3MBTL1
SCHEMBL27456239 0.83 NPC1 (0.59) ALDH1A1NPC1TSHRHPGDMEN1
SCHEMBL15040863 0.82 MEN1 (0.55) ALDH1A1NPC1HPGDMEN1KMT2A
SCHEMBL7706487 0.78 ALDH1A1 (0.60) ALDH1A1NPC1TSHRHPGDKDM4E
SCHEMBL19703776 0.77 ALDH1A1 (0.58) ALDH1A1NPC1TSHRHPGDKDM4E
SCHEMBL25934419 0.77 ALDH1A1 (0.58) ALDH1A1NPC1TSHRHPGDKDM4E
SCHEMBL21477198 0.76 NPC1 (0.46) ALDH1A1NPC1TSHRHPGDKDM4E
SCHEMBL12410266 0.76 NPC1 (0.62) ALDH1A1NPC1HPGDKDM4EMEN1
SCHEMBL10274470 0.76 NPC1 (0.74) ALDH1A1NPC1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024020221-A1 MODULATORS OF TYK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-01-25 — — WO disclosed
WO-2021194878-A1 SELECTIVE MODULATORS OF MUTANT LRRK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2021-09-30 — — WO disclosed
WO-2021077010-A1 BIFUNCTIONAL MOLECULES CONTAINING AN E3 UBIQUITINE LIGASE BINDING MOIETY LINKED TO A BCL6 TARGETING MOIETY ARVINAS OPERATIONS, INC. (US) 2021-04-22 — — WO disclosed
Send feedback